76-90 of 847

Advancing Pediatric MS Care: Insights from AAN 2026
NeuroFrontiersAdvancing Pediatric MS Care: Insights from AAN 2026

Family Planning in Patients with Multiple Sclerosis
NeuroFrontiersFamily Planning in Patients with Multiple Sclerosis

Strengthening Global Infrastructure for FSHD Trials
AudioAbstractsStrengthening Global Infrastructure for FSHD Trials

Spinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
NeuroFrontiersSpinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk

Early ALS Patients Show Slowed Decline with Pridopidine Treatment
NeuroFrontiersEarly ALS Patients Show Slowed Decline with Pridopidine Treatment
- advertisement

Rethinking Progression in Multiple Sclerosis
NeuroFrontiersRethinking Progression in Multiple Sclerosis

The Burden of Cognitive Dysfunction in Multiple Sclerosis
NeuroFrontiersThe Burden of Cognitive Dysfunction in Multiple Sclerosis

Switching to Risdiplam Maintains Motor Gains in SMA Patients
AudioAbstractsSwitching to Risdiplam Maintains Motor Gains in SMA Patients

Who’s Missing from Multiple Sclerosis Research?
NeuroFrontiersWho’s Missing from Multiple Sclerosis Research?

GFAP and VEGF Trajectories in Adult Type 3 Spinal Muscular Atrophy Under Nusinersen
NeuroFrontiersGFAP and VEGF Trajectories in Adult Type 3 Spinal Muscular Atrophy Under Nusinersen
- advertisement

CK1δ Inhibition and Riluzole in ALS: Synergy at Lower Doses
NeuroFrontiersCK1δ Inhibition and Riluzole in ALS: Synergy at Lower Doses

Multiple Sclerosis Without Borders: Taking a Global View
NeuroFrontiersMultiple Sclerosis Without Borders: Taking a Global View

Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care
NeuroFrontiersMultiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care






























